Product Overview
[Drug Name]
Trade Name: Gaishilong
English Name: Irsogladine Maleate Tablets
Chinese Pinyin: MalaiSuanYiSuoLaDingPian
[Ingredients]
The main ingredient of this product is irsogladine maleate. Its chemical name is 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine maleate. Molecular formula: C9H7Cl2N5·C4H4O4. Molecular weight: 372.17
[Properties]
This product is a white or off-white tablet.
[Indications]
Gastric ulcer, improvement of acute and chronic gastritis, and acute gastric mucosal lesions (erosion, bleeding, redness, edema).
[Dosage and Administration]
Oral administration: 4 mg (2 tablets) daily, divided into 1-2 doses. The dose may be adjusted appropriately based on age and symptoms.
[Adverse Reactions]
Occasionally, dizziness, nausea, vomiting, constipation, diarrhea, rash, loss of appetite, upper abdominal discomfort, and occasionally mild, reversible elevations in aminotransferase levels may occur.
[Contraindications]
Not yet known.
[Precautions]
1. If a rash occurs, discontinue the drug. 2. Elderly patients should start with a low dose (2 mg/day) and adjust the dose appropriately based on the severity of the reaction. Please read the instructions carefully and follow your doctor's instructions.
[Use in Special Populations]
Precautions for children: Not yet known.
Precautions for pregnancy and lactation: Not yet known.
Precautions for the elderly: Not yet known.
[Drug Interactions]
Not yet known.
[Pharmacological Actions]
This product is a gastric mucosal protective agent. It strengthens the adhesion between gastric epithelial cells, inhibits epithelial cell detachment and shedding, and widens the intercellular spaces. It enhances the stability of the mucosal cells themselves, thereby exerting a mucosal defense function and inhibiting the passage of harmful substances through the mucosa. Its mechanism of action is related to increasing the levels of cAMP, prostaglandins, reduced glutathione, and mucus glycoproteins in gastric mucosal cells. Experimental studies have shown that this product can inhibit hydrochloric acid- and ethanol-induced gastric mucosal cell dysfunction and increase gastric mucosal blood flow. The effect is dose-dependent.
Storage
Store in a tightly closed, dry place.
Specifications
2 mg
Packaging
2 mg x 10 seconds/box
Expiry Date
24 months
Approval Number
National Medicine Standard No. HJ20150259
Manufacturer
Zhaoke Pharmaceutical (Guangzhou) Co., Ltd. (formerly Zhaoke Pharmaceutical (Hefei) Co., Ltd.)
